human autologous serum as a substitute for fetal bovine serum in human schwann cell culture.

Authors

parisa goodarzi clinical grade cell manufacturing facility, brain and spinal cord injury research center, tehran university of medical sciences, tehran, iran.

babak arjmand clinical grade cell manufacturing facility, brain and spinal cord injury research center, tehran university of medical sciences, tehran, iran. and endocrinology and metabolism research center, endocrinology and metabolism research institute, tehran university of medical sciences. tehran, iran.

seyed hassan emami-razavi clinical grade cell manufacturing facility, brain and spinal cord injury research center, tehran university of medical sciences, tehran, iran.

masoud soleimani department of hematology, tarbiat modares university, tehran, iran.

abstract

nowadays, cell -based and tissue engineered products have opened new horizons in treatment of incurable nervous system disorders. the number of studies on the role of schwann cells (sc) in treating nervous disorders is higher than other cell types. different protocols have been suggested for isolation and expansion of sc which most of them have used multiple growth factors, mitogens and fetal bovine sera (fbs) in culture medium. because of potential hazards of animal-derived reagents, this study was designed to evaluate the effect of replacing fbs with human autologous serum (has) on sc's yield and culture parameters. samples from 10 peripheral nerve biopsies were retrieved and processed under aseptic condition. the isolated cells cultured in fbs (1st group) or autologous serum (2nd group). after primary culture the cells were seeded at 10000 cell/cm2 in a 12 wells cell culture plate for each group. at 100% confluency, the cell culture parameters (count, viability, purity and culture duration) of 2 groups were compared using paired t-test. the average donors' age was 35.80 (sd=13.35) and except for 1 sample the others cultured successfully. in first group, the averages of cell purity, viability and culture duration were 97% (sd=1.32), 97/33% (sd=1.22) and 11.77 (sd=2.58) days respectively. this parameters were 97.33% (sd=1.00), 97.55% (sd=1.33) and 10.33 days (sd=1.65) in second group. the difference of cell count, purity and viability were not significant between 2 groups (p>0.05). the cells of second group reached to 100% confluency in shorter period of time (p=0.03). the results of this study showed that autologous serum can be a good substitute for fbs in human sc culture. this can reduce the costs and improve the safety of cell product for clinical application.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Human autologous serum as a substitute for fetal bovine serum in human Schwann cell culture.

Nowadays, cell -based and tissue engineered products have opened new horizons in treatment of incurable nervous system disorders. The number of studies on the role of Schwann cells (SC) in treating nervous disorders is higher than other cell types. Different protocols have been suggested for isolation and expansion of SC which most of them have used multiple growth factors, mitogens and fetal b...

full text

Alternatives to the use of fetal bovine serum: human platelet lysates as a serum substitute in cell culture media.

The search for alternatives to the use of fetal bovine serum (FBS) in cell and tissue culture media has become a major goal in terms of the 3R principles in order to reduce or to avoid harvesting of FBS from bovine fetuses, and, in terms of Good Manufacturing Practice (GMP), to ensure safe and animal product-free conditions for biomedical tissue engineering and (adult) stem cell therapy, respec...

full text

Human AB serum as an alternative to fetal bovine serum for endothelial and cancer cell culture.

In vitro methods are widely used in biomedical research and industry, often reducing or replacing animal experiments. However, cell cultures are generally supplemented with fetal bovine serum (FBS), also known as fetal calf serum (FCS), to optimize cell growth. Concerns have been raised regarding both the method used to collect the serum from the donor fetus and the possibility of viral contami...

full text

Systematic evaluation of sericin protein as a substitute for fetal bovine serum in cell culture

Fetal bovine serum (FBS) shows obvious deficiencies in cell culture, such as low batch to batch consistency, adventitious biological contaminant risk, and high cost, which severely limit the development of the cell culture industry. Sericin protein derived from the silkworm cocoon has become increasingly popular due to its diverse and beneficial cell culture characteristics. However, systematic...

full text

Human-derived alternatives to fetal bovine serum in cell culture.

OBJECTIVE The need for an alternative to fetal bovine serum (FBS) is known to scientists and users involved in cell therapy or advanced therapy medicinal products. Human serum (huS) and platelet lysate (hPL) can be used as alternatives resulting in similar or even superior results concerning cell expansion. METHODS We developed protocols for the production of huS and two types of hPL and test...

full text

Differentiation of adipose-derived stem cells into Schwann-like cells: fetal bovine serum or human serum?

Access to autologous Schwann cells is limited due to lack of donor site and its difficult isolation and culture. Therefore, one of the possible ways to obtain to Schwann cells is to differentiate mesenchymal stem cells into glial pathway using various materials and protocols. The aim of this study was to compare the effects of fetal bovine serum and human serum on Schwann cell differentiation o...

full text

My Resources

Save resource for easier access later


Journal title:
acta medica iranica

جلد ۵۲، شماره ۴، صفحات ۲۴۱-۲۴۵

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023